Kato K - Search Results

1

KEYNOTE-975 study design: a Phase III study of definitive chemoradiotherapy plus pembrolizumab in patients with esophageal carcinoma.

Shah MA, Bennouna J, Doi T, Shen L, Kato K, Adenis A, Mamon HJ, Moehler M, Fu X, Cho BC, Bordia S, Bhagia P, Shih CS, Desai A, Enzinger P. Shah MA, et al. Among authors: kato k. Future Oncol. 2021 Apr;17(10):1143-1153. doi: 10.2217/fon-2020-0969. Epub 2021 Feb 3. Future Oncol. 2021. PMID: 33533655 Free PMC article. Clinical Trial.

2

A phase I trial of 5-fluorouracil with cisplatin and concurrent standard-dose radiotherapy in Japanese patients with stage II/III esophageal cancer.

Nakajima TE, Ura T, Ito Y, Kato K, Minashi K, Nihei K, Hironaka S, Boku N, Kagami Y, Muro K. Nakajima TE, et al. Among authors: kato k. Jpn J Clin Oncol. 2009 Jan;39(1):37-42. doi: 10.1093/jjco/hyn125. Jpn J Clin Oncol. 2009. PMID: 19103671 Clinical Trial.

3

Phase I/II study of capecitabine plus oxaliplatin (XELOX) plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer.

Doi T, Boku N, Kato K, Komatsu Y, Yamaguchi K, Muro K, Hamamoto Y, Sato A, Koizumi W, Mizunuma N, Takiuchi H. Doi T, et al. Among authors: kato k. Jpn J Clin Oncol. 2010 Oct;40(10):913-20. doi: 10.1093/jjco/hyq069. Epub 2010 May 12. Jpn J Clin Oncol. 2010. PMID: 20462981 Free PMC article. Clinical Trial.

4

Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906).

Kato K, Muro K, Minashi K, Ohtsu A, Ishikura S, Boku N, Takiuchi H, Komatsu Y, Miyata Y, Fukuda H; Gastrointestinal Oncology Study Group of the Japan Clinical Oncology Group (JCOG). Kato K, et al. Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):684-90. doi: 10.1016/j.ijrobp.2010.06.033. Epub 2010 Oct 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20932658 Clinical Trial.

5

Phase I study of NK012, a novel SN-38-incorporating micellar nanoparticle, in adult patients with solid tumors.

Hamaguchi T, Doi T, Eguchi-Nakajima T, Kato K, Yamada Y, Shimada Y, Fuse N, Ohtsu A, Matsumoto S, Takanashi M, Matsumura Y. Hamaguchi T, et al. Among authors: kato k. Clin Cancer Res. 2010 Oct 15;16(20):5058-66. doi: 10.1158/1078-0432.CCR-10-0387. Epub 2010 Oct 13. Clin Cancer Res. 2010. PMID: 20943763 Clinical Trial.

6

[Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer(JO19380)].

Sato A, Doi T, Boku N, Kato K, Komatsu Y, Yamaguchi K, Muro K, Hamamoto Y, Koizumi W, Mizunuma N, Takiuchi H. Sato A, et al. Among authors: kato k. Gan To Kagaku Ryoho. 2011 Apr;38(4):561-9. Gan To Kagaku Ryoho. 2011. PMID: 21498982 Clinical Trial. Japanese.

7

Phase II clinical trial of second-line FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: AVASIRI trial.

Horita Y, Yamada Y, Kato K, Hirashima Y, Akiyoshi K, Nagashima K, Nakajima T, Hamaguchi T, Shimada Y. Horita Y, et al. Among authors: kato k. Int J Clin Oncol. 2012 Dec;17(6):604-9. doi: 10.1007/s10147-011-0331-2. Epub 2011 Oct 15. Int J Clin Oncol. 2012. PMID: 22002492 Clinical Trial.

8

Phase II study of bolus 5-fluorouracil and leucovorin combined with weekly paclitaxel as first-line therapy for advanced gastric cancer.

Matsubara J, Shimada Y, Kato K, Nagai Y, Iwasa S, Nakajima TE, Hamaguchi T, Yamada Y, Takagi S, Kobayashi K, Yoshioka A, Nakayama N, Tsuji A. Matsubara J, et al. Among authors: kato k. Oncology. 2011;81(5-6):291-7. doi: 10.1159/000334462. Epub 2011 Nov 30. Oncology. 2011. PMID: 22134040 Clinical Trial.

9

Long-term results of a phase II study of S-1 plus irinotecan in metastatic colorectal cancer.

Iwasa S, Yamada Y, Kato K, Goto A, Honma Y, Hamaguchi T, Shimada Y. Iwasa S, et al. Among authors: kato k. Anticancer Res. 2012 Sep;32(9):4157-61. Anticancer Res. 2012. PMID: 22993378 Clinical Trial.

10

Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.

Kato K, Nakajima TE, Ito Y, Katada C, Ishiyama H, Tokunaga SY, Tanaka M, Hironaka S, Hashimoto T, Ura T, Kodaira T, Yoshimura K. Kato K, et al. Jpn J Clin Oncol. 2013 Jun;43(6):608-15. doi: 10.1093/jjco/hyt048. Epub 2013 Apr 12. Jpn J Clin Oncol. 2013. PMID: 23585687 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,689 results

Search Page